TARS Sale Disclosure
Neervannan Seshadri · SEC Form 4 · Filed Sep 9, 2026
Sale
Calculated transaction value
$387.94K
Neervannan Seshadri Chief Operating Officer
TARS
Transaction date
Sep 4, 2026
Public filing date
Sep 9, 2026
Filing lag
Filed 5 days later
TARS daily price context
Close on/before transaction
$90.78
Sep 4, 2026
Close before public filing
$87.22
Sep 8, 2026
Return since public filing
-9.07%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 4,564 shares @ $85
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001827584-26-000013
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$387.94K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. TARS Current | Sale | Sep 4, 2026 | $387.94K |